Mycal Casey, DO, MPH,
@MycalCasey
Followers
227
Following
2K
Media
119
Statuses
367
Hem/Onc fellow @GeorgetownHOF🩸🦀 #SpartanDO📚#MSUPublicHealth @MCG_InternalMed👨🏻⚕️ Interested in Myeloid Malignancies #leusm and Transplant #bmtsm
Augusta, GA
Joined December 2021
Victory lap weekend with @TinaRoyMD . We both worked the very first weekend of fellowship, and today we are finishing.
0
2
19
RT @GCC_Cortes: The first issue of @BloodGlobalHema is out with great hematology research from all other the world. @BloodPortfolio @ASH_he….
0
16
0
Seeing that end date on my last contract for training is surreal. One year to go!.
0
0
2
I need a drug company to have a clinical trial theme with espresso drinks. Latte-2, cappuccino-1, etc. Then during medical decision making we can say “based on Cortado-5…”.
1
0
1
Finishing out the last few days on the Oncology consult service!
0
0
5
AQUILA: Only 18% of control arm received Dara. The CI for this was 0.27 to 0.98. It’s hard to believe there would OS benefit in 2024,when most patients have Dara with tx. Also unlikely to be statistical significance if there was more crossover. Not to mention other limitations.
0
0
1
Great crew, well deserved!.
Excited for our 3rd year fellows all matching at their top choices for advanced fellowship! @KayShahbazian @drgemmohan @docakshatm Khalil Jalkh and Walker Barmore. #fellowshipmatch . @Deya_AlkhatibMD @aroravis @MusaSharkawiMD
0
0
1
“Education is the most powerful weapon which you can use to change the world”. -Nelson Mandela
1
1
9
RT @GCC_Cortes: On this Global CML Day, a reminder of the need to ensure that no CML patient is left behind. @icmlf @GACancerCenter https:/….
0
16
0
Practicing his illustration skills for the next manuscript submission
1
0
6
RT @GCC_Cortes: Much work still to be done to ensure progress in CML reaches patients all over the world as shown in our recent manuscript….
mdpi.com
Background: Evaluating clinical trial representation for countries with different socio-demographic index (SDI) and tyrosine kinase inhibitor (TKI) availability for chronic myeloid leukemia (CML)....
0
4
0
Check it out our article in CANCERS!. Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia . #mdpicancers via @Cancers_MDPI @GCC_Cortes @GACancerCenter @LombardiCancer @GeorgetownHOF.
mdpi.com
Background: Evaluating clinical trial representation for countries with different socio-demographic index (SDI) and tyrosine kinase inhibitor (TKI) availability for chronic myeloid leukemia (CML)....
0
1
8
‘Schedule send�� emails is the biggest game changer. Obviously, you can’t choose 8am on the dot. 8:37am, allow them to get that cup of coffee in, and morning meeting out of the way.
0
0
1